Membership: Join my YouTube channel membership and unlock exclusive perks! As a member, you'll get early access to videos to stay ahead with the latest content before anyone else. Investor tier members get access to my spreadsheets, and VIP discord members get access to our private discord community
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 29 Nov 2025, 11:00 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The video discusses HIMS, a telehealth company experiencing rapid growth. It emphasizes the volatility of the stock, with price swings of 10-20% regularly. A scenario analysis is conducted based on earnings per share (EPS) for 2027, estimated at $0.88. It explores forward P/E ratios, currently at 55. If the company maintains this forward PE and achieves the EPS target, the stock price could increase to $48.40. Increased to a P/E multiple of 60, it could reach $52.80. However, it also posits scenarios where a decrease in the forward PE multiple to 50 could limit the stock price to $44, and a further decrease to 45 could cap it at $39.60. The analyst sees that the stock price could increase next year and that's largely dependent on the company hitting that earnings per share of 0.88 in 2027.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
